Synergetics Biomedical 2025 Q4 Financial Report
NQ Score
57/100
N1 Content Completeness
3
AI Summary (NQ-processed)
Synergetics Biomedical Investment Holdings Co., Ltd. announced its Q4 2025 financial results, reporting a basic EPS of 1.00 NTD, operating revenue of 4.398 billion NTD, and a net income after tax of 226 million NTD.
AI analysis data is not yet available.